An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

✍ Scribed by J.M Michon; O Hartmann; E Bouffet; V Meresse; C Coze; H Rubie; P Bordigoni; E Cattiaux; N Ward; J.-L Bernard; J Lemerle; J.-M Zucker; T Philip

• Book ID: 117665788
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 148 KB
• Volume: 34
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(98)00061-6